GSK 2021 Oncology Medical Congress
Our approach is #InspiredByCuriosity
At ESMO, we are proud to share 13 data presentations, showcasing our ongoing efforts to research and develop potentially transformational medicines for patients with cancer. We are recognised for pioneering science, exploring new frontiers of research and forging new paths in healthcare. Underlying our ability to achieve the innovation that leads to transformational medicines is a single, remarkable quality: curiosity.
Inspired by our individual and collective curiosity, we are unafraid to ask complicated, catalysing, propelling questions and pursue the answers with flexibility, openness and zeal.
We believe learning is an ongoing process, and that answers often inspire more questions, all of which are the paving stones for new paths forward.
Learn more about our transformational science
Advancing the next wave of immuno-oncology
Cancer is complex. Learn more about how we are driving research into a diverse portfolio of novel immuno-oncology therapies and combinations that may have the potential to change cancer as we know it.
For more information about GSK
Our media resource centre
Our resource centre houses additional details about GSK-related stories and news
Research and development
Learn more about how we’re working to prevent and treat disease with vaccines, specialty and general medicines
Go Behind the Science to learn more
Advancing the Next Generation of Immuno-Oncology
We're researching a portfolio of novel immuno-oncology therapies & combinations that may have the potential to change cancer as we know it
Immuno-Oncology: Integrating innovation into standard of care practice
In today’s remarkable field of Immuno-Oncology, there is still much yet to discover.